Overview

VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The primary efficacy objective of this study is to study the efficacy in terms of response rate to alternating bortezomib/dexamethasone regimen
Phase:
Phase 2
Details
Lead Sponsor:
PETHEMA Foundation
Treatments:
BB 1101
Bortezomib
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate